VIA
RYTM icon

Virtus Investment Advisers’s Rhythm Pharmaceuticals RYTM Stock Holding History

Virtus Investment Advisers’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
13,158
+5,724
+77% +$518K 0.34% 125
2026
Q1 		$647K Buy
7,434
+1,417
+24% +$138K 0.18% 186
2025
Q4 		$644K Sell
6,017
-1,035
-15% -$110K 0.18% 207
2025
Q3 		$712K Hold
7,052
– – 0.2% 166
2025
Q2 		$446K Buy
7,052
+606
+9% +$37.1K 0.15% 201
2025
Q1 		$341K Buy
+6,446
New +$358K 0.09% 231

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Virtus Investment Advisers's RYTM Position: Q2 2026 in Review

Virtus Investment Advisers increased its Rhythm Pharmaceuticals (RYTM) stake by 77% in Q2 2026, buying an estimated $518K and bringing the position to 13,158 shares worth $1.46M. The position accounts for 0.34% of the portfolio, ranked #125.

Virtus Investment Advisers first reported a position in RYTM in Q1 2025 and has held it in 6 quarters since. 303 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Virtus Investment Advisers held 13,158 shares of Rhythm Pharmaceuticals worth $1.46M as of Q2 2026.
  • Virtus Investment Advisers bought 5,724 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $518K.
  • Rhythm Pharmaceuticals made up 0.34% of Virtus Investment Advisers's portfolio in Q2 2026, its #125 holding.
  • Virtus Investment Advisers first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 303 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.